Facial Erythema Treatment Market by Product and Geography - Forecast and Analysis 2022-2026

Published: Feb 2022 Pages: 120 SKU: IRTNTR72324

The facial erythema treatment market share is expected to increase by USD 106.32 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.01%.

This facial erythema treatment market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers facial erythema treatment market segmentation by product (topical and oral) and geography (North America, Europe, Asia, and ROW). The facial erythema treatment market report also offers information on several market vendors, including Bausch Health Companies Inc., Bayer AG, Galderma SA, GlaxoSmithKline Plc, LEO Pharma AS, Merck and Co. Inc., Novartis AG, Pfizer Inc., and Regeneron Pharmaceuticals Inc. among others.

What will the Facial Erythema Treatment Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Facial Erythema Treatment Market Size for the Forecast Period and Other Important Statistics

 

Facial Erythema Treatment Market: Key Drivers, Trends, and Challenges

The strategic initiatives of market players is notably driving the facial erythema treatment market growth, although factors such as side effects associated with facial erythema treatment drugs may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the facial erythema treatment industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Facial Erythema Treatment Market Driver

The strategic initiatives of market players is one of the key drivers supporting the facial erythema treatment market growth. Vendors in the global facial erythema treatment market are increasingly focusing on strategic developments, such as product enhancements and innovations, to extend their product portfolios. For instance, in July 2021, Sol-Gel Technologies Ltd., a dermatology company that develops generic topical drug products for the treatment of skin diseases, announced that the FDA had approved its first proprietary drug product, TWYNEO. The product is a tretinoin/benzoyl peroxide-based cream, which can be used for the treatment of lesions caused due to acne vulgaris in adults and pediatric patients nine years of age and older. Thus, the growing number of product development and collaborations undertaken by vendors in the market is expected to support the growth of the market during the forecast period.

Key Facial Erythema Treatment Market Trend

The increased healthcare spending worldwide is another factor supporting the facial erythema treatment market growth. According to The World Health Organization (WHO), the global spending on healthcare continually increased between 2000 and 2018 and reached $8.3 trillion or 10% of global GDP. In 2020, the US spent 19.7% of its GDP on healthcare expenditure. Other European nations such as Germany, France, Sweden, and Austria spent 11.43%, 11.26%, 10.90%, and 10.33%, respectively, of their GDP on healthcare expenditure. Furthermore, the expenditure on prescription drugs and over-the-counter medicines has increased in recent years. Thus, the increasing expenditure in the global healthcare sector and the increase in government aid to healthcare providers will boost the growth of the global facial erythema treatment market during the forecast period.

Key Facial Erythema Treatment Market Challenge

The side effects associated with facial erythema treatment drugs is one of the factors hindering the facial erythema treatment market growth. The FDA has provided approval for the topical use of oxymetazoline 0.05% solution for the treatment of rosacea. The usage of oxymetazoline has resulted in improvement in facial erythema and erythematous flares as it offers relief in stinging and burning of the skin. However, many side effects of oxymetazoline have been reported. These include application site dermatitis, pain, paresthesia, and pruritus. It can also lead to the worsening of facial inflammatory lesions of rosacea. Thus, the side effects associated with the usage of facial erythema treatment drugs can result in the reduced usage of these drugs. These market challenges can negatively impact the growth of the global facial erythema treatment market during the forecast period.

This facial erythema treatment market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the facial erythema treatment market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the facial erythema treatment market during the forecast period.

Who are the Major Facial Erythema Treatment Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

  • Bausch Health Companies Inc.
  • Bayer AG
  • Galderma SA
  • GlaxoSmithKline Plc
  • LEO Pharma AS
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.

 

This statistical study of the facial erythema treatment market encompasses successful business strategies deployed by the key vendors. The facial erythema treatment market is concentrated and the vendors are deploying growth strategies such as the launch of new products, product approvals, joint ventures, acquisitions, partnerships, expansion projects, collaborations, and investments to compete in the market.

Product Insights and News

  • Bausch Health Companies Inc. - The company offers facial erythema treatment that provides effective treatment for pulsed dye, pulsed KTP, and pulsed Nd YAG lasers, and IPL sources, using large spot sizes to avoid reticulation.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The facial erythema treatment market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Facial Erythema Treatment Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the facial erythema treatment market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chains is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The value chain of the pharmaceuticals market includes the following core components:

  • Research and development (R&D) and drug discovery
  • Integration and product development
  • Manufacturing
  • Outbound logistics
  • Marketing and sales
  • Support activities
  • Innovations

The report has further elucidated on other innovative approaches being followed by service providers to ensure a sustainable market presence.

 

Which are the Key Regions for Facial Erythema Treatment Market?

For more insights on the market share of various regions Request for a FREE sample now!

41% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for the facial erythema treatment market in North America. Market growth in this region will be slower than the growth of the market in Asia.

The high prevalence of rosacea will facilitate the facial eryth`ema treatment market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the COVID-19 pandemic had a negative impact on the regional facial erythema treatment market. The governments of various countries such as the US, Canada, and Mexico, imposed nationwide lockdowns to curb the spread of the disease. However, in H2 2020, due to the availability of vaccines and the vaccination drives conducted by governments in the region, there was a reduction in the number of COVID-19 cases. Supply chain disruptions faced by regional vendors were eased, which led to the availability of various medications for the treatment of facial erythema. Thus, the regional market will continue to witness growth during the forecast period.

What are the Revenue-generating Product Segments in the Facial Erythema Treatment Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The facial erythema treatment market share growth by the tropical segment will be significant during the forecast period. Facial erythema can be caused by common inflammatory skin diseases such as perioral dermatitis, rosacea, and systemic illness. Various factors leading to facial erythema include sun exposure, extreme temperatures, alcohol consumption, hot drinks, and spicy food, among others. There are several types of facial erythema, with different patterns and color variations like red, purple, or brown. They can be treated with various drugs, which can be administered topically. Thus, the market segment will continue to witness growth due to the increased preference for using topical drugs for the treatment of facial erythema.

This report provides an accurate prediction of the contribution of all the segments to the growth of the facial erythema treatment market size and actionable market insights on post COVID-19 impact on each segment.

 

Facial Erythema Treatment Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 5.01%

Market growth 2022-2026

$ 106.32 million

Market structure

Concentrated

YoY growth (%)

4.50

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 41%

Key consumer countries

US, Germany, UK, China, and Canada

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Bausch Health Companies Inc., Bayer AG, Galderma SA, GlaxoSmithKline Plc, LEO Pharma AS, Merck and Co. Inc., Novartis AG, Pfizer Inc., and Regeneron Pharmaceuticals Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Facial Erythema Treatment Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive facial erythema treatment market growth during the next five years
  • Precise estimation of the facial erythema treatment market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the facial erythema treatment industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of facial erythema treatment market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

***1. Executive Summary                           

***2. Market Landscape                             

                **2.1 Market ecosystem             

                                *Exhibit 01:  Parent market

                                *Exhibit 02:  Market characteristics

                **2.2 Value chain analysis           

                                *Exhibit 03:  Value chain analysis: Pharmaceuticals

                                *2.2.1 Research and development (R&D) and drug discovery

                                *2.2.2 Integration and product development

                                *2.2.3 Manufacturing:

                                *2.2.4 Outbound logistics

                                *2.2.5 Marketing and sales

                                *2.2.6 Support activities

                                *2.2.7 Innovations

***3. Market Sizing                       

                **3.1 Market definition

                                *Exhibit 04:  Offerings of vendors included in the market definition

                **3.2 Market segment analysis 

                                *Exhibit 05:  Market segments

                **3.3 Market size 2021 

                **3.4 Market outlook: Forecast for 2021 - 2026 

                                *3.4.1 Estimating growth rates for emerging and high-growth markets

                                *3.4.2 Estimating growth rates for mature markets

                                *Exhibit 06:  Global - Market size and forecast 2021 - 2026 ($ million)

                                *Exhibit 07:  Global market: Year-over-year growth 2021 - 2026 (%)

***4. Five Forces Analysis                          

                **4.1 Five Forces Summary        

                                *Exhibit 08:  Five forces analysis 2021 & 2026

                **4.2 Bargaining power of buyers           

                                *Exhibit 09:  Bargaining power of buyers

                **4.3 Bargaining power of suppliers       

                                *Exhibit 10: Bargaining power of suppliers

                **4.4 Threat of new entrants    

                                *Exhibit 11:  Threat of new entrants

                **4.5 Threat of substitutes         

                                *Exhibit 12: Threat of substitutes

                **4.6 Threat of rivalry   

                                *Exhibit 13: Threat of rivalry

                **4.7 Market condition

                                *Exhibit 14:  Market condition - Five forces 2021

***5. Market Segmentation by Product               

                **5.1 Market segments

                                *The segments covered in this chapter are:

  • Topical
  • Oral

                                *Exhibit 15:  Product- Market share 2021-2026 (%)

                **5.2 Comparison by Product    

                                *Exhibit 16:  Comparison by Product

                **5.3 Topical - Market size and forecast 2021-2026          

                                *Exhibit 17:  Topical - Market size and forecast 2021-2026 ($ million)

                                *Exhibit 18:  Topical - Year-over-year growth 2021-2026 (%)

                **5.4 Oral - Market size and forecast 2021-2026

                                *Exhibit 19:  Oral - Market size and forecast 2021-2026 ($ million)

                                *Exhibit 20:  Oral - Year-over-year growth 2021-2026 (%)

                **5.5 Market opportunity by Product    

                                *Exhibit 21:  Market opportunity by Product

***6. Customer landscape                         

                                *Technavio’s customer landscape matrix comparing Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate and Key purchase criteria

                                *Exhibit 22:  Customer landscape

***7. Geographic Landscape                     

                **7.1 Geographic segmentation

                                *The regions covered in the report are:

  • North America
  • Europe
  • Asia
  • ROW

                                *Exhibit 23:  Market share by geography 2021-2026 (%)

                **7.2 Geographic comparison   

                                *Exhibit 24:  Geographic comparison

                **7.3 North America - Market size and forecast 2021-2026           

                                *Exhibit 25:  North America - Market size and forecast 2021-2026 ($ million)

                                *Exhibit 26:  North America - Year-over-year growth 2021-2026 (%)

                **7.4 Europe - Market size and forecast 2021-2026          

                                *Exhibit 27:  Europe - Market size and forecast 2021-2026 ($ million)

                                *Exhibit 28:  Europe - Year-over-year growth 2021-2026 (%)

                **7.5 Asia - Market size and forecast 2021-2026

                                *Exhibit 29:  Asia - Market size and forecast 2021-2026 ($ million)

                                *Exhibit 30:  Asia - Year-over-year growth 2021-2026 (%)

                **7.6 ROW - Market size and forecast 2021-2026              

                                *Exhibit 31:  ROW - Market size and forecast 2021-2026 ($ million)

                                *Exhibit 32:  ROW - Year-over-year growth 2021-2026 (%)

                **7.7 Key leading countries        

                                *Exhibit 33:  Key leading countries

                **7.8 Market opportunity by geography

                                *Exhibit 34:  Market opportunity by geography ($ million)

***8. Drivers, Challenges, and Trends                   

                **8.1 Market drivers     

                                *8.1.1 Strategic initiatives of market players

                                *8.1.2 Changing climatic conditions

                                *8.1.3 High demand for antibiotics for the treatment of rosacea

                **8.2 Market challenges              

                                *8.2.1 Side effects associated with facial erythema treatment drugs

                                *8.2.2 Stringent government regulations

                                *8.2.3 Increased use of generic drugs

                                *Exhibit 35:  Impact of drivers and challenges

                **8.3 Market trends      

                                *8.3.1 Increased healthcare spending worldwide

                                *8.3.2 Growth in R&D related to dermatological diseases

                                *8.3.3 Increased rate of patient population

***9. Vendor Landscape                             

                **9.1 Overview

                                *Exhibit 36:  Vendor landscape

                **9.2 Landscape disruption        

                                *Exhibit 37:  Landscape disruption

                                *Exhibit 38:  Industry risks

***10. Vendor Analysis               

                **10.1 Vendors covered              

                                *Exhibit 39:  Vendors covered

                **10.2 Market positioning of vendors    

                                *Exhibit 40: Market positioning of vendors

                **10.3 Bausch Health Companies Inc.    

                                *Exhibit 41:  Bausch Health Companies Inc. - Overview

                                *Exhibit 42:  Bausch Health Companies Inc. - Business segments

                                *Exhibit 43:  Bausch Health Companies Inc. - Key offerings

                                *Exhibit 44:  Bausch Health Companies Inc. - Segment focus

                **10.4 Bayer AG             

                                *Exhibit 45:  Bayer AG - Overview

                                *Exhibit 46:  Bayer AG - Business segments

                                *Exhibit 47:  Bayer AG-Key news

                                *Exhibit 49:  Bayer AG - Segment focus

                **10.5 Galderma SA      

                                *Exhibit 50:  Galderma SA - Overview

                                *Exhibit 51:  Galderma SA - Product and service

                                *Exhibit 52:  Galderma SA - Key offerings

                **10.6 GlaxoSmithKline Plc         

                                *Exhibit 53:  GlaxoSmithKline Plc - Overview

                                *Exhibit 54:  GlaxoSmithKline Plc - Business segments

                                *Exhibit 55:  GlaxoSmithKline Plc - Key offerings

                                *Exhibit 56:  GlaxoSmithKline Plc - Segment focus

                **10.7 LEO Pharma AS  

                                *Exhibit 57:  LEO Pharma AS - Overview

                                *Exhibit 58:  LEO Pharma AS - Business segments

                                *Exhibit 59:  LEO Pharma AS - Key offerings

                                *Exhibit 60:  LEO Pharma AS - Segment focus

                **10.8 Merck and Co. Inc.           

                                *Exhibit 61:  Merck and Co. Inc. - Overview

                                *Exhibit 62:  Merck and Co. Inc. - Business segments

                                *Exhibit 63:  Merck and Co. Inc. - Key offerings

                                *Exhibit 64:  Merck and Co. Inc. - Segment focus

                **10.9 Novartis AG        

                                *Exhibit 65:  Novartis AG - Overview

                                *Exhibit 66:  Novartis AG - Business segments

                                *Exhibit 67:  Novartis AG - Key offerings

                                *Exhibit 68:  Novartis AG - Segment focus

                **10.10 Pfizer Inc.          

                                *Exhibit 69:  Pfizer Inc. - Overview

                                *Exhibit 70:  Pfizer Inc. - Business segments

                                *Exhibit 71:  Pfizer Inc. - Key offerings

                                *Exhibit 72:  Pfizer Inc. - Segment focus

                **10.11 Regeneron Pharmaceuticals Inc.             

                                *Exhibit 73:  Regeneron Pharmaceuticals Inc. - Overview

                                *Exhibit 74:  Regeneron Pharmaceuticals Inc. - Product and service

                                *Exhibit 75:  Regeneron Pharmaceuticals Inc. - Key offerings

***11. Appendix                            

                **11.1 Scope of the report         

                                *11.1.1 Market definition

                                *11.1.2 Objectives

                                *11.1.3 Notes and caveats

                **11.2 Currency conversion rates for US$            

                                *Exhibit 76:  Currency conversion rates for US$

                **11.3 Research Methodology 

                                *Exhibit 77:  Research Methodology

                                *Exhibit 78:  Validation techniques employed for market sizing

                                *Exhibit 79:  Information sources

                **11.4 List of abbreviations        

                                *Exhibit 80:  List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

PURCHASE FULL REPORT OF

facial erythema treatment market

QUICK BUY

Key Questions Answered

  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis